Discover 533 paid clinical trials in Memphis, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 533
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Location: Memphis TN, Birmingham AL, St Louis MO, Atlanta GA,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT04851119
Phase 1, Phase 2, Recruiting
CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia
for
Acute Lymphoblastic Leukemia,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0 - 21
Code: NCT06777979
Phase 1, Recruiting
Long-term Follow-up After Adoptive Transfer of Genetically Modified Cell Products
for
Relapsed Hematologic Malignancy,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0+
Code: NCT05713214
Recruiting
Barriers and Facilitators of Parent-Child Communication in Children With Cancer Predisposition
for
Genetic Predisposition
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 10 - 24
Code: NCT05849155
Recruiting
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
for
HIV Infection
Location: Memphis TN, Chicago IL, Houston TX, Jacksonville FL,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 0
Code: NCT02140255
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors
for
Solid Tumor
Location: Memphis TN, Chicago IL, Pittsburgh PA
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0 - 20
Code: NCT05645523
Early Phase 1, Recruiting
International Pediatric Adrenocortical Tumor Registry
for
Adrenocortical Tumor
Location: Memphis TN, Dayton OH
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0 - 21
Code: NCT00700414
Recruiting
Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
for
Rhabdomyosarcoma
Location: Memphis TN, Palo Alto CA
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0 - 22
Code: NCT06023641
Phase 2, Recruiting
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer